fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

GSK position regarding the acquisition of Vectura by Philip Morris International (PMI)

Written by | 16 Sep 2021

Following the news of the acquisition of Vectura by Philip Morris International (PMI), we would like to clarify GSK’s position regarding Ellipta inhalers and their association with Vectura.

Pharmacist led Type 2 diabetes intervention reverses medication use

Written by | 16 Sep 2021

Persons with Type 2 diabetes can, through diet and pharmacist supervision, eliminate the need for diabetes medications, researchers reported on Sept. 10, 2021 in Nature Communications. “There is… read more.

SOPHIA Phase III study of Margenza announces final OS data in HER2-positive breast cancer patients – MacroGenics

Written by | 15 Sep 2021

MacroGenics announced the final overall survival (OS) results of the SOPHIA Phase III study of Margenza (margetuximab-cmkb) in adult patients with metastatic HER2-positive breast cancer. The final OS… read more.

How a racing heart may alter decision-making brain circuits

Written by | 15 Sep 2021

Anxiety, addiction, and other psychiatric disorders are often characterized by intense states of what scientists call arousal: The heart races, blood pressure readings rise, breaths shorten, and “bad”… read more.

Horizon Therapeutics initiates randomized controlled clinical trial evaluating Tepezza for the treatment of chronic (inactive) thyroid eye disease

Written by | 14 Sep 2021

Horizon Therapeutics plc has announced that the first patient has been enrolled in a Phase IV clinical trial evaluating the efficacy and safety of Tepezza for the treatment… read more.

Plant-based diet associated with lower risk of covid infection and less severe disease

Written by | 14 Sep 2021

In a recent study led by researchers at Massachusetts General Hospital (MGH) and Kings College Hospital published in Gut, people whose diets were based on healthy plant-based foods… read more.

Statistical model defines ketamine anesthesia’s effects on the brain

Written by | 13 Sep 2021

By developing the first statistical model to finely characterize how ketamine anesthesia affects the brain, a team of researchers at MIT’s Picower Institute for Learning and Memory and… read more.

“Polypill” with aspirin cuts fatal outcome in cardiovascular disease

Written by | 13 Sep 2021

Combination therapy with aspirin, statins and at least two blood pressure drugs significantly lowers the risk of developing fatal cardiovascular disease (CVD) researchers reported on August 29, 2021… read more.

Stem-like T cells could aid immunotherapy in cancer treatment

Written by | 12 Sep 2021

In a new study by Yale Cancer Center, researchers show stem-like T cells within certain lymph nodes could be natural cancer fighters. Targeting these T cells, which are… read more.

Drug cocktail reduces aging-associated disc degeneration

Written by | 12 Sep 2021

Chronic back pain affects upwards of 15 million adults in the US, racking up billions in healthcare costs and lost work days. Degeneration of the discs that cushion… read more.

The Bristol-Myers Squibb-Pfizer Alliance welcomes the decision by the U.S. Court of Appeals for the Federal Circuit upholding the Eliquis Patents

Written by | 11 Sep 2021

The Bristol-Myers Squibb-Pfizer Alliance issued the following statement: We welcome the decision by the Court of Appeals for the Federal Circuit’s to affirm the U.S. District Court’s August… read more.

Gut bacteria influence brain development

Written by | 11 Sep 2021

Researchers discover biomarkers that indicate early brain injury in extreme premature infants University of Vienna Extremely premature infants are at a high risk for brain damage. Researchers have… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.